Klebsiella pneumoniae carbapenemase variants: the new threat to global public health

Performance standards for antimicrobial susceptibility testing

Ferraro, M. J. (2001) · Cited by 9,780

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.

Liu, Y.-Y., Wang, Y., Walsh, T., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G.-B., Dong, B.-L., Huang, X.-H., et al. (2016) · Lancet. Infectious Diseases (Print) · doi:10.1016/s1473-3099(15)00424-7 · Cited by 4,920

Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae

Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K. P., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,389

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections

Doi, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz830 · Cited by 661

Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding

Chen, L., Mathema, B., Chavda, K. D., DeLeo, F. R., Bonomo, R. A., & Kreiswirth, B. N. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.003 · Cited by 554

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR- P. aeruginosa )

Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac268 · Cited by 554

New β-Lactam–β-Lactamase Inhibitor Combinations

Yahav, D., Giske, C. G., Grāmatniece, A., Abodakpi, H., Tam, V. H., & Leibovici, L. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00115-20 · Cited by 550

Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258

Kitchel, B., Rasheed, J. K., Patel, J. B., Srinivasan, A., Navon‐Venezia, S., Carmeli, Y., Brolund, A., & Giske, C. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00126-09 · Cited by 523

Genetic Structures at the Origin of Acquisition of the β-Lactamase bla KPC Gene

Naas, T., Cuzon, G., Villegas, M. V., Lartigue, M.-F., Quinn, J. P., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-07 · Cited by 516

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

Shields, R. K., Chen, L., Cheng, S., Chavda, K. D., Press, E. G., Snyder, A. C., Pandey, R., Doi, Y., Kreiswirth, B. N., Nguyen, M. H., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02097-16 · Cited by 489

Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention

Schwaber, M. J., Lev, B., Israeli, A., Solter, E., Smollan, G., Rubinovitch, B., Shalit, I., Carmeli, Y., & the Israel Carbapenem-Resistant Enterobacteriaceae Working Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir025 · Cited by 452

Rescuing the Last-Line Polymyxins: Achievements and Challenges

Nang, S. C., Azad, M. A. K., Velkov, T., Zhou, Q. (., & Li, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000020 · Cited by 428

Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae

Pierce, V., Simner, P. J., Lonsway, D. R., Roe, D. E., Johnson, J. K., Brasso, W. B., Bobenchik, A. M., Lockett, Z. C., Charnot‐Katsikas, A., Ferraro, M. J., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00193-17 · Cited by 411

Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China

Han, R., Shi, Q., Wu, S., Yin, D., Peng, M., Dong, D., Zheng, Y., Guo, Y. P., Zhang, R., Hu, F., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00314 · Cited by 388

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

Zhanel, G. G., Lawrence, C. K., Adam, H. J., Schweizer, F., Zelenitsky, S. A., Zhanel, M. A., Lagacé-Wiens, P. R. S., Walkty, A. J., Denisuik, A. J., Golden, A., et al. (2017) · Drugs · doi:10.1007/s40265-017-0851-9 · Cited by 380

Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

Wang, M., Earley, M. J., Chen, L., Hanson, B., Yu, Y., Liu, Z., Salcedo, S., Cober, E., Li, L., Kanj, S. S., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00399-6 · Cited by 366

Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused byKlebsiella pneumoniaeCarbapenemase–producingK. pneumoniae

Tumbarello, M., Trecarichi, E. M., Corona, A., Rosa, F. G. D., Bassetti, M., Mussini, C., Menichetti, F., Viscoli, C., Campoli, C., Venditti, M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy492 · Cited by 358

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

Capone, A., Giannella, M., Fortini, D., Giordano, A., Meledandri, M., Ballardini, M., Venditti, M., Bordi, E., Capozzi, D., Balice, M. P., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12070 · Cited by 345

ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China

Yan, Q., Wei, Z., Ji, S., Du, X., Shen, P., & Yu, Y. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq431 · Cited by 345

Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review

Yaghoubi, S., Zekiy, A. O., Krůtová, M., Gholami, M., Kouhsari, E., Sholeh, M., Ghafouri, Z., & Maleki, F. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04121-1 · Cited by 332

Worldwide Diversity ofKlebsiella pneumoniaeThat Produce β-LactamaseblaKPC-2Gene1

Cuzon, G., Naas, T., Truong, H. T., Villegas, M. V., Wisell, K. T., Carmeli, Y., Gales, A. C., Navon‐Venezia, S., Quinn, J. P., & Nordmann, P. (2010) · Emerging infectious diseases · doi:10.3201/eid1609.091389 · Cited by 308

Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study

Tumbarello, M., Raffaelli, F., Giannella, M., Mantengoli, E., Mularoni, A., Venditti, M., Rosa, F. G. D., Sarmati, L., Bassetti, M., Brindicci, G., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab176 · Cited by 283

First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate

Humphries, R. M., Yang, S., Hemarajata, P., Ward, K. W., Hindler, J. A., Miller, S. A., & Gregson, A. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-15 · Cited by 256

A simple phenotypic method for the differentiation of metallo- -lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates

Tsakris, A., Poulou, A., Pournaras, S., Voulgari, E., Vrioni, G., Themeli-Digalaki, K., Petropoulou, D., & Sofianou, D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq210 · Cited by 242

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States

Bartsch, S. M., McKinnell, J. A., Mueller, L. E., Miller, L. G., Gohil, S. K., Huang, S. S., & Lee, B. Y. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.09.003 · Cited by 220

The β‐Lactams Strike Back: Ceftazidime‐Avibactam

Zasowski, E. J., Rybak, J. M., & Rybak, M. J. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1622 · Cited by 219

Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in bla KPC-2 -Harboring Klebsiella pneumoniae Sequence Type 307 Isolates

Giddins, M. J., Maćešić, N., Annavajhala, M. K., Stump, S., Khan, S. D., McConville, T. H., Mehta, M., Gomez‐Simmonds, A., & Uhlemann, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-17 · Cited by 219

Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis

Martin, A. L., Fahrbach, K. R., Zhao, Q., & Lodise, T. P. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy150 · Cited by 217

Dissemination of bla KPC-2 by the Spread of Klebsiella pneumoniae Clonal Complex 258 Clones (ST258, ST11, ST437) and Plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae Species in Brazil

Andrade, L. N., Curião, T., Ferreira, J. C., Longo, J. M., Clímaco, E. C., Martínez, R., Bellissimo‐Rodrigues, F., Basile-Filho, A., Evaristo, M. A., Peloso, P. F. D., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01783-10 · Cited by 194

Novel Genetic Environment of the Carbapenem-Hydrolyzing β-Lactamase KPC-2 among Enterobacteriaceae in China

Shen, P., Wei, Z., Jiang, Y., Du, X., Ji, S., Yu, Y., & Li, L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00260-09 · Cited by 187

Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-Lactamase

Papp‐Wallace, K. M., Bethel, C. R., Distler, A. M., Kasuboski, C., Taracila, M. A., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00693-09 · Cited by 180

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Castanheira, M., Huband, M. D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00567-17 · Cited by 171

In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment

Gaibani, P., Campoli, C., Lewis, R. E., Volpe, S. L., Scaltriti, E., Giannella, M., Pongolini, S., Berlingeri, A., Cristini, F., Bartoletti, M., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky082 · Cited by 171

Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance

Linkevičius, M., Sandegren, L., & Andersson, D. I. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02465-15 · Cited by 166

In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)

DeJonge, B. L. M., Karlowsky, J. A., Kazmierczak, K. M., Biedenbach, D. J., Sahm, D. F., & Nichols, W. W. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03042-15 · Cited by 162

Multisite Evaluation of Cepheid Xpert Carba-R Assay for Detection of Carbapenemase-Producing Organisms in Rectal Swabs

Tato, M., Ruíz-Garbajosa, P., Traczewski, M. M., Dodgson, A. R., McEwan, A. K., Humphries, R. M., Hindler, J. A., Veltman, J., Wang, H., & Cantón, R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00341-16 · Cited by 150

Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City

Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Quale, J. M., & Landman, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00843-15 · Cited by 147

Simple Disk-Based Method for Detection of Klebsiella pneumoniae Carbapenemase-Type β-Lactamase by Use of a Boronic Acid Compound

Doi, Y., Potoski, B. A., Adams‐Haduch, J. M., Sidjabat, H. E., Pasculle, A. W., & Paterson, D. L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01408-08 · Cited by 145

Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340)

Pereira, P. S., de Araújo, C. F. M., Seki, L. M., Zahner, V., Carvalho-Assef, A. P. D., & Asensi, M. D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks396 · Cited by 143

Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae

Haidar, G., Clancy, C. J., Chen, L., Samanta, P., Shields, R. K., Kreiswirth, B. N., & Nguyen, M. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00642-17 · Cited by 142

A Rapid Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Method for Single-Plasmid Tracking in an Outbreak of Carbapenem-Resistant Enterobacteriaceae

Lau, A. F., Wang, H., Weingarten, R. A., Drake, S. K., Suffredini, A. F., Garfield, M. K., Chen, Y., Guček, M., Youn, J.-H., Stock, F., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00694-14 · Cited by 139

In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)

Lob, S. H., Hackel, M., Kazmierczak, K. M., Young, K., Motyl, M. R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02209-16 · Cited by 138

Detection of KPC Carbapenem-Hydrolyzing Enzymes in Enterobacter spp. from Brooklyn, New York

Bratu, S., Landman, D., Alam, M., Tolentino, E., & Quale, J. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.776-778.2005 · Cited by 130

Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature

Shields, R. K., Nguyen, M. H., Press, E. G., Chen, L., Kreiswirth, B. N., & Clancy, C. J. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx101 · Cited by 130

A Concise Synthesis of a β-Lactamase Inhibitor

Mangion, I. K., Ruck, R. T., Rivera, N. R., Huffman, M. A., & Shevlin, M. (2011) · Organic Letters · doi:10.1021/ol202195n · Cited by 125

EDTA-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Metallo-β-Lactamase-Producing Enterobacteriaceae

Sfeir, M. M., Hayden, J. A., Fauntleroy, K. A., Mazur, C., Johnson, J. K., Simner, P. J., Das, S., Satlin, M. J., Jenkins, S. G., & Westblade, L. F. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01757-18 · Cited by 124

Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4

Wolter, D. J., Kurpiel, P. M., Woodford, N., Palepou, M.-F. I., Goering, R. V., & Hanson, N. D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00734-08 · Cited by 115

Global Dissemination of bla KPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam

Kazmierczak, K. M., Biedenbach, D. J., Hackel, M., Rabine, S., DeJonge, B. L. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00107-16 · Cited by 107

Pandemic spread of bla among Klebsiella pneumoniae ST11 in China is associated with horizontal transfer mediated by IncFII-like plasmids

Fu, P., Tang, Y., Li, G., Yu, L., Wang, Y., & Jiang, X. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.03.014 · Cited by 106

Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa

Yin, D., Wu, S., Yang, Y., Shi, Q., Dong, D., Zhu, D., & Hu, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02431-18 · Cited by 103

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae

Papp‐Wallace, K. M., Barnes, M. D., Alsop, J., Taracila, M. A., Bethel, C. R., Becka, S. A., van Duin, D., Kreiswirth, B. N., Kaye, K. S., & Bonomo, R. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00174-18 · Cited by 101

Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae : experience from a national registry study

Karaiskos, I., Daikos, G. L., Gkoufa, A., Adamis, G., Stefos, A., Symbardi, S., Chrysos, G., Filiou, E., Basoulis, D., Mouloudi, E. K., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa503 · Cited by 101

Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo

Göttig, S., Frank, D., Mungo, E., Nolte, A., Hogardt, M., Besier, S. M., & Wichelhaus, T. A. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz330 · Cited by 98

All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials

McGovern, P. C., Wible, M., El‐Tahtawy, A., Biswas, P., & Meyer, R. D. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.01.020 · Cited by 97

Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates

Carattoli, A., Arcari, G., Bibbolino, G., Sacco, F., Tomolillo, D., Lella, F. M. D., Trancassini, M., Faino, L., Venditti, M., Antonelli, G., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-21 · Cited by 97

In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme

Pfaller, M. A., Huband, M. D., Mendes, R. E., Flamm, R. K., & Castanheira, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.02.021 · Cited by 96

Emergence and Recovery of Ceftazidime-avibactam Resistance inblaKPC-33-HarboringKlebsiella pneumoniaeSequence Type 11 Isolates in China

Shi, Q., Yin, D., Han, R., Guo, Y. P., Zheng, Y., Wu, S., Yang, Y., Li, S., Zhang, R., & Hu, F. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1521 · Cited by 89

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient

Athans, V., Neuner, E. A., Hassouna, H., Richter, S. S., Keller, G., Castanheira, M., Brizendine, K. D., & Mathers, A. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01551-18 · Cited by 88

Current status and trends of antimicrobial resistance among clinical isolates in China: a retrospective study of CHINET from 2018 to 2022

Yang, W., Ding, L., Han, R., Yin, D., Wu, S., Yang, Y., Zhu, D., Guo, Y. B., Hu, F., on behalf of the China Antimicrobial Surveillance Network (CHINET) Study Group, et al. (2023) · One Health Advances · doi:10.1186/s44280-023-00009-9 · Cited by 88

Evaluation of the NG-Test CARBA 5 multiplex immunochromatographic assay for the detection of KPC, OXA-48-like, NDM, VIM and IMP carbapenemases

Hopkins, K. L., Meunier, D., Naas, T., Volland, H., & Woodford, N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky342 · Cited by 87

Phenotypic, Biochemical, and Genetic Analysis of KPC-41, a KPC-3 Variant Conferring Resistance to Ceftazidime-Avibactam and Exhibiting Reduced Carbapenemase Activity

Mueller, L., Masseron, A., Prod’hom, G., Galperine, T. K., Greub, G., Poirel, L., & Nordmann, P. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01111-19 · Cited by 79

Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity

Oueslati, S., Iorga, B. I., Tlili, L., Exilie, C., Zavala, A. J., Dortet, L., Jousset, A. B., Bernabeu, S., Bonnin, R. A., & Naas, T. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz209 · Cited by 77

The Spread ofKlebsiella pneumoniaeCarbapenemases: A Tale of Strains, Plasmids, and Transposons

Munoz-Price, L. S., & Quinn, J. P. (2009) · Clinical Infectious Diseases · doi:10.1086/648078 · Cited by 76

Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019

Sader, H. S., Carvalhaes, C. G., Arends, S. J. R., Castanheira, M., & Mendes, R. E. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa504 · Cited by 76

Phenotypic and Genotypic Characterization ofEnterobacteriaceaeProducing Oxacillinase-48–Like Carbapenemases, United States

Lutgring, J. D., Zhu, W., de Man, T. J. B., Avillan, J. J., Anderson, K. F., Lonsway, D. R., Rowe, L. A., Batra, D. G., Rasheed, J. K., & Limbago, B. M. (2018) · Emerging infectious diseases · doi:10.3201/eid2404.171377 · Cited by 74

Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variants

Poirel, L., Sadek, M., Kusaksizoglu, A., & Nordmann, P. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04397-x · Cited by 69

A carbapenem-resistant Klebsiella pneumoniae epidemic clone in Jerusalem: sequence type 512 carrying a plasmid encoding aac(6')-Ib

Warburg, G., Hidalgo‐Grass, C., Partridge, S. R., Tolmasky, M. E., Temper, V., Moses, A. E., Block, C., & Strahilevitz, J. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr552 · Cited by 66

Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-Avibactam

Alsenani, T. A., Viviani, S. L., Kumar, V., Taracila, M. A., Bethel, C. R., Barnes, M. D., Papp‐Wallace, K. M., Shields, R. K., Nguyen, M. H., Clancy, C. J., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02414-21 · Cited by 66

Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals during 2016 to 2018

Castanheira, M., Doyle, T. B., Kantro, V., Mendes, R. E., & Shortridge, D. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01951-19 · Cited by 65

Complete Sequence of a bla KPC-2 -Harboring IncFII K1 Plasmid from a Klebsiella pneumoniae Sequence Type 258 Strain

Chen, L., Chavda, K. D., Melano, R. G., Jacobs, M. R., Levi, M. H., Bonomo, R. A., & Kreiswirth, B. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02332-12 · Cited by 63

Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae

Tian, Y., Zhang, Q., Wen, L., & Chen, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00152-21 · Cited by 62

Emergence of ceftazidime-avibactam-resistant Klebsiella pneumoniae during treatment, Finland, December 2018

Räisänen, K., Koivula, I., Ilmavirta, H., Puranen, S., Kallonen, T., Lyytikäinen, O., & Jalava, J. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.19.1900256 · Cited by 60

Enhanced Klebsiella pneumoniae Carbapenemase Expression from a Novel Tn 4401 Deletion

Cheruvanky, A., Stoesser, N. E., Sheppard, A. E., Crook, D. W., Hoffman, P. S., Weddle, E. A., Carroll, J., Sifri, C. D., Chai, W., Barry, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00025-17 · Cited by 59

In Vitro Activity of Cefepime-Zidebactam, Ceftazidime-Avibactam, and Other Comparators against Clinical Isolates of Enterobacterales , Pseudomonas aeruginosa, and Acinetobacter baumannii: Results from China Antimicrobial Surveillance Network (CHINET) in 2018

Yang, Y., Guo, Y. P., Yin, D., Zheng, Y., Wu, S., Zhu, D., & Hu, F. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01726-20 · Cited by 59

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae –Producing KPC-31, a D179Y Variant of KPC-3

Tiseo, G., Falcone, M., Leonildi, A., Giordano, C., Barnini, S., Arcari, G., Carattoli, A., & Menichetti, F. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab141 · Cited by 59

Rapid Identification of Five Classes of Carbapenem Resistance Genes Directly from Rectal Swabs by Use of the Xpert Carba-R Assay

Moore, N. M., Cantón, R., Carretto, E., Peterson, L. R., Sautter, R. L., & Traczewski, M. M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00137-17 · Cited by 58

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam

Galani, I., Antoniadou, A., Karaiskos, I., Κοντοπούλου, Κ., Giamarellou, H., & Souli, M. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.011 · Cited by 56

KPC-31 expressed in a ceftazidime/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues

Antonelli, A., Giani, T., Pilato, V. D., Riccobono, E., Perriello, G., Mencacci, A., & Rossolini, G. M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz156 · Cited by 55

RamA upregulates multidrug resistance efflux pumps AcrAB and OqxAB in Klebsiella pneumoniae

Xu, Q., Sheng, Z.-K., Hao, M., Jiang, J., Ye, M., Chen, Y., Xu, X., Guo, Q., & Wang, M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106251 · Cited by 55

In Vitro Activity of New β-Lactam–β-Lactamase Inhibitor Combinations and Comparators against Clinical Isolates of Gram-Negative Bacilli: Results from the China Antimicrobial Surveillance Network (CHINET) in 2019

Guo, Y. P., Han, R., Jiang, B., Ding, L., Yang, F., Zheng, B., Yang, Y., Wu, S., Yin, D., Zhu, D., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01854-22 · Cited by 54

Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature

Cano, Á., Guzmán-Puche, J., García‐Gutiérrez, M., Castón, J. J., Gracia-Ahufinger, I., Pérez‐Nadales, E., Recio, M., Natera, A. M., Marfil, E., Martı́nez-Martı́nez, L., et al. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.11.007 · Cited by 53

Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience

Bianco, G., Boattini, M., Iannaccone, M., Bondi, A., Ghibaudo, D., Zanotto, E., Peradotto, M., Cavallo, R., & Costa, C. S. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.02.008 · Cited by 49

Comparison of Four Carbapenemase Detection Methods for bla KPC-2 Variants

Ding, L., Shi, Q., Han, R., Yin, D., Wu, S., Yang, Y., Guo, Y., Zhu, D., & Hu, F. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00954-21 · Cited by 48

Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis

Angelis, G. D., Grossi, A., Menchinelli, G., Boccia, S., Sanguinetti, M., & Posteraro, B. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.009 · Cited by 47

KPC-50 Confers Resistance to Ceftazidime-Avibactam Associated with Reduced Carbapenemase Activity

Poirel, L., Vuillemin, X., Juhas, M., Masseron, A., Bechtel-Grosch, U., Tiziani, S., Mancini, S., & Nordmann, P. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00321-20 · Cited by 47

Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background

Sun, L., Chen, W., Li, H., Li, L., Zou, X., Zhao, J., Lu, B., Li, B., Wang, C., Li, H., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa241 · Cited by 44

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

Galani, I., Karaiskos, I., Angelidis, E., Papoutsaki, V., Galani, L., Souli, M., Antoniadou, A., & Giamarellou, H. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04000-9 · Cited by 43

Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection

Hernández-García, M., Castillo-Polo, J. A., Cordero, D., Pérez-Viso, B., García-Castillo, M., de la Fuente, J. S., Morosini, M. I., Cantón, R., & Ruíz-Garbajosa, P. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.02245-21 · Cited by 43

Multiple Novel Ceftazidime-Avibactam-Resistant Variants of bla KPC-2 -Positive Klebsiella pneumoniae in Two Patients

Shi, Q., Han, R., Guo, Y. P., Yang, Y., Wu, S., Ding, L., Zhang, R., Yin, D., & Hu, F. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01714-21 · Cited by 41

Klebsiella pneumoniae and Klebsiella quasipneumoniae define the population structure of blaKPC-2Klebsiella: a 5 year retrospective genomic study in Singapore

Octavia, S., Marimuthu, K., Venkatachalam, I., Ng, O. T., Wei-zhen, X., Sridatta, P. S. R., Ong, Y. F., Wang, L. D., Chua, A., Cheng, B., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz332 · Cited by 38

Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: considerations regarding acquired heteroresistance and choice of carbapenemase detection assay

Bianco, G., Boattini, M., Iannaccone, M., Cavallo, R., & Costa, C. S. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa283 · Cited by 36

Insights into the Lignocellulose-Degrading Enzyme System of Humicola grisea var. thermoidea Based on Genome and Transcriptome Analysis.

Blasco, L., Ibarguren-Quiles, C., López-Causapé, C., et al. (2021) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.1128/spectrum · Cited by 35

Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae

Lee, Y. R., & Baker, N. T. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3260-4 · Cited by 33

Activity of imipenem/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance

Carpenter, J., Neidig, N., Campbell, A., Thornsberry, T., Truex, T., Fortney, T., Zhang, Y., & Bush, K. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz354 · Cited by 33

A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring bla KPC-14 Isolated in New York City

Niu, S., Chavda, K. D., Wei, J., Zou, C., Marshall, S. H., Dhawan, P., Wang, D., Bonomo, R. A., Kreiswirth, B. N., & Chen, L. (2020) · mSphere · doi:10.1128/msphere.00775-20 · Cited by 33

Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant Klebsiella pneumoniae Clone in China

Li, X., Quan, J., Ke, H., Wu, W., Feng, Y., Yu, Y., & Jiang, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.724272 · Cited by 31

KPC-53, a KPC-3 Variant of Clinical Origin Associated with Reduced Susceptibility to Ceftazidime-Avibactam

Pilato, V. D., Aiezza, N., Viaggi, V., Antonelli, A., Principe, L., Giani, T., Luzzaro, F., & Rossolini, G. M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01429-20 · Cited by 30

A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate

Yang, Q., Li, Y., Li, F., Lei, T., Cai, H., Hua, X., Zheng, M., & Yu, Y. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.10.013 · Cited by 30

Multicenter Performance Assessment of Carba NP Test

Cunningham, S. A., Limbago, B. M., Traczewski, M. M., Anderson, K. F., Hackel, M., Hindler, J. A., Sahm, D., Alyanak, E., Lawsin, A., Gulvik, C. A., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00244-17 · Cited by 29

Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain

Castillo-Polo, J. A., Hernández-García, M., Morosini, M. I., Pérez-Viso, B., Soriano, C., Pablo, R. D., Cantón, R., & Ruíz-Garbajosa, P. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad086 · Cited by 29

Genomic characterization of a Klebsiella pneumoniae ST1519 resistant to ceftazidime/avibactam carrying a novel KPC variant (KPC-36)

Gaibani, P., Ambretti, S., Campoli, C., Viale, P., & Re, M. C. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.09.020 · Cited by 28

Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant Enterobacterales Isolates Associated with Bloodstream Infection

Huang, Y., Kuo, Y.-W., Lee, N., Tien, N., Liao, C., Teng, L., Ko, W., & Hsueh, P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01728-21 · Cited by 28

Emergence of the New KPC-49 Variant Conferring an ESBL Phenotype with Resistance to Ceftazidime-Avibactam in the ST131-H30R1 Escherichia coli High-Risk Clone

Hernández-García, M., López, J. S., Martínez-García, L., Becerra-Aparicio, F., Morosini, M. I., Ruíz-Garbajosa, P., & Cantón, R. (2021) · Pathogens · doi:10.3390/pathogens10010067 · Cited by 27

Characterization of a Multidrug-Resistant Porcine Klebsiella pneumoniae Sequence Type 11 Strain Coharboring bla KPC-2 and fosA3 on Two Novel Hybrid Plasmids

Zhang, W., Zhu, Y., Wang, C., Liu, W., Li, R., Chen, F., Luan, T., Zhang, Y., Schwarz, Š., & Liu, S. (2019) · mSphere · doi:10.1128/msphere.00590-19 · Cited by 26

Ceftazidime–Avibactam Resistance Mutations V240G, D179Y, and D179Y/T243M in KPC-3 β-Lactamase Do Not Alter Cefpodoxime–ETX1317 Susceptibility

Shapiro, A. B., Moussa, S. H., Carter, N., Gao, N., & Miller, A. A. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00575 · Cited by 26

Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient

Gaibani, P., Amadesi, S., Lazzarotto, T., & Ambretti, S. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.06.021 · Cited by 26

Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina

Nicola, F., Cejas, D., González-Espinosa, F., Relloso, S., Herrera, F., Bonvehí, P., Smayevsky, J., Figueroa-Espinosa, R. A., Gutkind, G., & Radice, M. A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03733-22 · Cited by 26

KPC-39-Mediated Resistance to Ceftazidime-Avibactam in a Klebsiella pneumoniae ST307 Clinical Isolate

Jousset, A. B., Oueslati, S., Emeraud, C., Bonnin, R. A., Dortet, L., Iorga, B. I., & Naas, T. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01160-21 · Cited by 25

First Description of Ceftazidime/Avibactam Resistance in a ST13 KPC-70-Producing Klebsiella pneumoniae Strain from Portugal

Mendes, G., Ramalho, J. F., Bruschy-Fonseca, A., Lito, L., Duarte, A., Melo‐Cristino, J., & Caneiras, C. S. G. (2022) · Antibiotics · doi:10.3390/antibiotics11020167 · Cited by 25

Emergence of a Fatal ST11-KL64 Tigecycline-Resistant Hypervirulent Klebsiella pneumoniae Clone Cocarrying bla NDM and bla KPC in Plasmids

Huang, J., Yi, M., Yuan, Y., Xia, P., Yang, B., Liao, J., Dang, Z., Luo, S., & Xia, Y. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02539-22 · Cited by 25

Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions

Bongiorno, D., Bivona, D. A., Cicino, C., Trecarichi, E. M., Russo, A., Marascio, N., Mezzatesta, M. L., Musso, N., Privitera, G. F., Quirino, A., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1010979 · Cited by 25

Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms

Gu, D., Yan, Z., Cai, C., Li, J., Zhang, Y., Wu, Y., Yang, J., Huang, Y., Zhang, R., & Wu, Y. (2023) · Antibiotics · doi:10.3390/antibiotics12020300 · Cited by 25

Comparative Analysis of bla KPC Expression in Tn 4401 Transposons and the Tn 3 -Tn 4401 Chimera

Huang, J., Hu, X., Zhao, Y., Shi, Y., Ding, H., Wu, R., Zhao, Z., & Ji, J. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02434-18 · Cited by 24

Patient-to-Patient Transmission of Klebsiella pneumoniae Carbapenemase Variants with Reduced Ceftazidime-Avibactam Susceptibility

Munoz-Price, L. S., Reeme, A. E., Buchan, B. W., Mettus, R. T., Mustapha, M. M., Tyne, D. V., Shields, R. K., & Doi, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00955-19 · Cited by 23

Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri

Lebreton, F., Corey, B. W., McElheny, C. L., Iovleva, A., Preston, L. N., Margulieux, K. R., Cybulski, R. J., McGann, P., Doi, Y., & Bennett, J. W. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00150-21 · Cited by 23

In vivo selection of KPC-94 and KPC-95 in Klebsiella pneumoniae isolates from patients treated with ceftazidime/avibactam

Guzmán-Puche, J., Pérez‐Nadales, E., Pérez-Vázquez, M. D., Causse, M., Gracia-Ahufinger, I., Natera, A. M., Allalou-Ruiz, Y., Elías-López, C., Oteo, J., Torre‐Cisneros, J., et al. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106524 · Cited by 22

Emergence of Escherichia coli Sequence Type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a Long-Term Care and Rehabilitation Facility (LTCRF) in Northern Italy

Piazza, A., Caltagirone, M., Bitar, I., Nucleo, E., Spalla, M., Fogato, E., D’Angelo, R., Pagani, L., & Migliavacca, R. (2015) · Advances in experimental medicine and biology · doi:10.1007/5584_2015_5017 · Cited by 21

Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report

Arcari, G., Oliva, A., Sacco, F., Lella, F. M. D., Raponi, G., Tomolillo, D., Curtolo, A., Venditti, M., & Carattoli, A. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04388-y · Cited by 21

Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China

Chen, X., Li, P., Sun, Z., Xu, X., Jiang, J., & Su, J. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.07.002 · Cited by 19

Ceftazidime–Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing Klebsiella pneumoniae

Ding, L., Shen, S., Han, R., Yin, D., Guo, Y. P., & Hu, F. (2022) · Antibiotics · doi:10.3390/antibiotics11050604 · Cited by 18

Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam

Shen, S., Tang, C., Ding, L., Han, R., Yin, D., Yang, W., Guo, Y. P., & Hu, F. (2022) · mSphere · doi:10.1128/msphere.00487-22 · Cited by 18

The changing face of Klebsiella pneumoniae carbapenemase: in-vivo mutation in patient with chest infection

Shen, S., Shi, Q., & Hu, F. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01011-x · Cited by 16

Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with?

Corcione, S., Benedetto, I. D., Shbaklo, N., Torsello, G., Lupia, T., Bianco, G., Cavallo, R., Brazzi, L., Montrucchio, G. G., & Rosa, F. G. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054767 · Cited by 16

A Novel KPC Variant KPC-55 in Klebsiella pneumoniae ST307 of Reinforced Meropenem-Hydrolyzing Activity

Yoon, E.-J., Choi, Y. J., Park, S. H., Shin, J. H., Park, S. G., Choi, J. R., & Jeong, S. H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.561317 · Cited by 12

Identification of a Novel Ceftazidime-Avibactam-Resistant KPC-2 Variant, KPC-123, in Citrobacter koseri Following Ceftazidime-Avibactam Treatment

Wang, L., Shen, W., Zhang, R., & Cai, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.930777 · Cited by 12

KPC-12 with a L169M substitution in the Ω loop has reduced carbapenemase activity

Qin, J., Feng, Y., Lu, X., & Zong, Z. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04198-2 · Cited by 10

A Two Amino Acid Duplication, L167E168, in the Ω-Loop Drastically Decreases Carbapenemase Activity of KPC-53, a Natural Class A β-Lactamase

Piccirilli, A., Cherubini, S., Celenza, G., Rossolini, G. M., Brisdelli, F., Segatore, B., Principe, L., Luzzaro, F., Andriani, L., Amicosante, G., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02402-21 · Cited by 6

Untitled work

Barbero (2014) · doi:10.1016/j · Cited by 1

Medicinal plants: bioactive compounds, biological activities, combating multidrug-resistant microorganisms, and human health benefits - a comprehensive review

El‐Saadony, M. T., Saad, A. M., Mohammed, D. M., Korma, S. A., Alshahrani, M. Y., Ahmed, A. E., Ibrahim, E. H., Salem, H. M., Alkafaas, S. S., Saif, A. M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1491777 · Cited by 291

Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A global public health threat

Lei, T.-Y., Liao, B.-B., Yang, L.-R., Wang, Y., & Chen, X.-B. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127839 · Cited by 140

ESKAPE in China: epidemiology and characteristics of antibiotic resistance

Luo, Q., Lu, P., Chen, Y., Shen, P., Zheng, B., Ji, J., Ying, C., Liu, Z., & Xiao, Y. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2317915 · Cited by 122

Epidemiology and Genetic Traits of Carbapenemase-Producing Enterobacterales: A Global Threat to Human Health

Alvisi, G., Curtoni, A., Fonnesu, R., Piazza, A., Signoretto, C., Piccinini, G., Sassera, D., & Gaibani, P. (2025) · Antibiotics · doi:10.3390/antibiotics14020141 · Cited by 97

Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use

Sartelli, M., Tascini, C., Coccolini, F., Dellai, F., Ansaloni, L., Antonelli, M. M., Bartoletti, M., Bassetti, M., Boncagni, F., Carlini, M., et al. (2024) · World Journal of Emergency Surgery · doi:10.1186/s13017-024-00551-w · Cited by 66

First report of KPC variants conferring ceftazidime-avibactam resistance in Colombia: introducing KPC-197

Cadena, E. D. L., Mojica, M. F., Rojas, L. J., Castro, B. E., García-Betancur, J. C., Marshall, S. H., Restrepo-Arbeláez, N., Castro-Caro, N. P., Fonseca-Carrillo, M., Pallares, C., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04105-23 · Cited by 9

Emergence of Ceftazidime‐Avibactam‐Induced KPC Variants (KPC‐25/127) in Intracranial Infection and Implications for Clinical Management

Lei, K., Tian, Y., Xiong, C., Lei, J., Chen, D., Bai, X., Abdul-Aziz, M. H., Xie, J., & Liu, Z. (2026) · MicrobiologyOpen · doi:10.1002/mbo3.70363

Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview

Hobson, C. A., Pierrat, G., Tenaillon, O., Bonacorsi, S., Berçot, B., Jaouen, E., Jacquier, H., & Birgy, A. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00447-22 · Cited by 226

Molecular characterisation of two novel KPC variants mediating ceftazidime-avibactam resistance in ST11 Klebsiella pneumoniae

Guo, T., Li, D., Shen, S., Tang, C., Jiang, T., & Hu, F. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107642 · Cited by 3

P-290. Clinical and microbiological characteristics of patients infected with ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing K. pneumoniae strains

Liu, S.-Y., Chou, S.-H., Chuang, C., Ho, Y.-C., Juan, C.-H., & Lin, Y.-T. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae631.493